Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.

International journal of hematology

Volumn 70, Issue 1, 1999, Pages 56-57

  Miyawaki, S ^a   Kobayashi, T ^a   Tanimoto, M ^a   Kuriyama, K ^a   Murakami, H ^a   Yoshida, M ^a   Minami, S ^a   Minato, K ^a   Tsubaki, K ^a   Omoto, E ^a   Oh, H ^a   Jinnai, I ^a   Sakamaki, H ^a   Hiraoka, A ^a   Kanamaru, A ^a   Takahashi, I ^a   Saito, K ^a   Naoe, T ^a   Yamada, O ^a   Asou, N ^a   Kageyama, S ^a   Emi, N ^a   Ueda, T ^a   Tomonaga, M ^a   Ohno, R ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CYTARABINE; DRUG DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LEUKOPENIA; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOPENIA; PROSPECTIVE STUDIES;

EID: 0033163349     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)